CTOs on the Move

GoHealth Urgent Care

www.gohealthuc.com

 
GoHealth Urgent Care is one of the countrys fastest-growing and largest urgent care providers. At GoHealth Urgent Care, we place the needs of our patients first—by providing an effortless patient experience, a welcoming culture of care and seamless integration with market-leading health systems and our communities. GoHealth Urgent Care operates 80 urgent care centers in the New York and Portland, Oregon, metropolitan areas, the San Francisco Bay Area, Hartford, Connecticut, and will soon open urgent care centers in multiple Midwest markets. GoHealth Urgent Cares current partners include health systems that are at the forefront of care delivery innovation, including Northwell ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million
  • www.gohealthuc.com
  • 5555 Glenridge Connector Suite 700
    Atlanta, GA USA 30342
  • Phone: 678.774.7100

Executives

Name Title Contact Details
Dan Golden
Vice President, Information Systems Profile
Andrew Neumann
Chief Information Officer Profile
Dev Ashish
Chief Information Officer Profile

Similar Companies

Bonfils Blood Center

Bonfils Blood Center Foundation was established in 1995 as the fundraising arm of Bonfils Blood Center and serves the core function of encouraging and managing philanthropy to support a variety of programs and initiatives for Bonfils Blood Center. From

Austills Rehabilitation Services

Austill's specializes in providing pediatric therapy services to School Districts, Early Intervention Programs, and County-Wide Regional Special Education providers. Since 1984, Austill's has provided therapy for educational programs. We customize all

Midwest Medical Svc

Midwest Medical Svc is a Charleston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PG Drives Technology

PG Drives Technology is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.